DBMF: A Good Alternative Diversifier
https://seekingalpha.com/article/4657311-dbmf-a-good-alternative-diversifier?source=feed_tag_etf_portfolio_strategy
Dec 11, 2023 - iMGP DBi Managed Futures Strategy is a suitable choice for investors looking for alternatives in their portfolios. Learn more about DBMF ETF here.
0
WTV: Good Value, But Average Quality And Performance
https://seekingalpha.com/article/4657175-wtv-good-value-but-average-quality-and-performance?source=feed_tag_etf_portfolio_strategy
Dec 11, 2023 - WisdomTree US Value Fund is an actively managed ETF with a strategy based on shareholder yield and quality metrics. Read more on WTV ETF here.
0
Wall Street Analysts Think Microsoft (MSFT) Is a Good Investment: Is It?
https://www.zacks.com/stock/news/2196123/wall-street-analysts-think-microsoft-msft-is-a-good-investment-is-it?cid=CS-ZC-FT-fundamental_analysis|average_broker_rating-2196123
Dec 11, 2023 - According to the average brokerage recommendation (ABR), one should invest in Microsoft (MSFT). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
0
Weekend Reading - Another Good Labor Report; Commodities Can't Catch A Bid
https://seekingalpha.com/article/4657133-weekend-reading-another-good-labor-report-commodities-cant-catch-bid?source=feed_all_articles
Dec 10, 2023 - The employment report showed another solid gain. The underlying data remained a bit mixed, but on the whole the job gains were broad and consistent with reasonably strong aggregate demand.
0
Struggling to Max Out Your 2023 IRA? Here's Some Good News.
https://www.fool.com/retirement/2023/12/09/struggling-to-max-out-your-2023-ira-heres-some-goo/?source=iedfolrf0000001
Dec 09, 2023 - Here's a reason to breathe more easily.
0
DHY: There Could Be A Good Argument For Buying This Junk Bond CEF Today
https://seekingalpha.com/article/4656929-dhy-there-could-be-a-good-argument-for-buying-this-junk-bond-cef-today?source=feed_tag_etf_portfolio_strategy
Dec 08, 2023 - The Credit Suisse High Yield Bond Fund offers attractive income generation through speculative-grade bonds. Click to see if the high DHY yield is right for you.
0
Digital Initiatives to Keep FEMSA (FMX) Stock in Good Stride
https://www.zacks.com/stock/news/2195560/digital-initiatives-to-keep-femsa-fmx-stock-in-good-stride?cid=CS-ZC-FT-analyst_blog|rank_focused-2195560
Dec 08, 2023 - FEMSA (FMX) is well-placed for growth through investments in digital and technology-driven initiatives, and continued strength in OXXO Mexico and OXXO Gas.
0
Wall Street Analysts Think Adma Biologics (ADMA) Is a Good Investment: Is It?
https://www.zacks.com/stock/news/2195418/wall-street-analysts-think-adma-biologics-adma-is-a-good-investment-is-it?cid=CS-ZC-FT-fundamental_analysis|average_broker_rating-2195418
Dec 08, 2023 - Based on the average brokerage recommendation (ABR), Adma Biologics (ADMA) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
0
ADM (ADM) Is Considered a Good Investment by Brokers: Is That True?
https://www.zacks.com/stock/news/2195427/adm-adm-is-considered-a-good-investment-by-brokers-is-that-true?cid=CS-ZC-FT-fundamental_analysis|average_broker_rating-2195427
Dec 08, 2023 - According to the average brokerage recommendation (ABR), one should invest in ADM (ADM). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
0
What Makes EyePoint Pharmaceuticals (EYPT) a Good Fit for 'Trend Investing'
https://www.zacks.com/stock/news/2195361/what-makes-eyepoint-pharmaceuticals-eypt-a-good-fit-for-trend-investing?cid=CS-ZC-FT-tale_of_the_tape|recent_price_strength_screen-2195361
Dec 08, 2023 - If you are looking for stocks that are well positioned to maintain their recent uptrend, EyePoint Pharmaceuticals (EYPT) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
0